ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

NCT00090363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ZD4054 15 mg
DRUG: Placebo
DRUG: ZD4054 10 mg

Sponsor

AstraZeneca